Specialty Pharmacy Insights

Many of the specialty medications used to treat complex, chronic conditions are delivered through limited distribution. Limited distribution drugs (LDD) are therapies only made available to a small number of pharmacies—and though there are reasons ...

Avella has always been dedicated to connecting its customers with the resources needed to make sound business and clinical decisions. Now we’ve introduced yet another way to do just that, with the release of our 2018 Specialty Medication Pipeline ...

The specialty pharmacy industry is relatively young compared to other healthcare sectors, with its origins tracing back to the early 1970s. However, this industry’s explosive growth has certainly made up for its late start. Specialty drug spending ...

In the time since IMBRUVICA® (ibrutinib) was first approved by the FDA in 2013 it has undergone many changes. This includes multiple indication expansions to various types of leukemia and lymphoma, approval as a first-line therapy, and even ...